home / stock / bio / bio news


BIO News and Press, Bio-Rad Laboratories Inc. Class A From 02/15/24

Stock Information

Company Name: Bio-Rad Laboratories Inc. Class A
Stock Symbol: BIO
Market: NYSE
Website: bio-rad.com

Menu

BIO BIO Quote BIO Short BIO News BIO Articles BIO Message Board
Get BIO Alerts

News, Short Squeeze, Breakout and More Instantly...

BIO - Expected US Company Earnings on Thursday, February 15th, 2024

Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...

BIO - Trading (BIO) With Integrated Risk Controls

2024-02-07 19:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BIO - Stocks with expensive valuations vs their peers - BofA

2024-02-07 13:43:49 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Stocks ...

BIO - Longleaf Partners Fund Q4 2023 Commentary

2024-01-31 06:05:00 ET Summary Longleaf Partners Funds is a suite of mutual funds and UCITS funds that Southeastern Asset Management, the investment advisor to the Longleaf Partners Funds, created in 1987 as a way for Southeastern employees to invest alongside their clients. 2023 ...

BIO - Danaher, Repligen rise as German peer Sartorius beats in Q4

2024-01-26 12:23:42 ET More on Bio-Rad Labs, Danaher, etc. Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics J.P. Morgan 42nd Annual Healthcare Conference Danaher Corporation (DHR) 42nd Annual JPMorgan Healthcare Conference (Transcript) Thermo...

BIO - These are the most neglected stocks within each sector - BofA

2024-01-25 11:31:54 ET More on S&P 500 Index: The Most Important New All-Time High Has Yet To Be Achieved Fed Preview: Expect Interest Rate Cuts In May, June, November And December Attention Turns To Lagarde's Press Conference And U.S. Q4 GDP These are th...

BIO - Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year 2023 on Thursday, February 15, 2024, following the close of the market. Management will discuss these...

BIO - Longleaf Partners Global Fund Q4 2023 Commentary

2024-01-20 09:00:00 ET Summary Longleaf Partners Funds is a suite of mutual funds and UCITS funds that Southeastern Asset Management, the investment advisor to the Longleaf Partners Funds, created in 1987 as a way for Southeastern employees to invest alongside their clients. Longl...

BIO - Health stocks to watch this earning season as sector poised for resurgence

2024-01-11 12:14:06 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tu...

BIO - Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 42nd Annual Healthcare Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, today announced that Norman Schwartz, President and CEO, and Andrew Last, Executive Vice President and COO, will host one-on-one meetings with investors during the 42nd Ann...

Previous 10 Next 10